The gift will support students in TSRI’s highly ranked graduate program.
The Lerner lab’s new method to isolate and analyze venoms opens the door to new, more potent therapeutics.
Research from the Kissil lab reveals the effects of celecoxib (Pfizer’s Celebrex®) in animal models.
The research from the Lazzerini Denchi lab also suggests a possible way to kill these types of tumors.
The findings from the Cline lab have implications for drug development.
King was formerly president and CEO of AcelRx Pharmaceuticals.
An outreach event for local San Diego high school students is made possible by TSRI graduate student volunteers.